Cancer Detection in Pancreatic Cysts
NCT00222898 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2007-02-19
Summary
The purpose of this study is to assist with early and accurate diagnosis of cancer in pancreatic cysts based on the analysis of DNA obtained by endoscopic ultrasound guided fine needle aspiration
Conditions
- Pancreatic Cyst
- Pancreatic Pseudocyst
- Pancreatic Neoplasm
Interventions
- PROCEDURE
-
DNA analysis of pancreatic cyst fluid / buccal swab
Sponsors & Collaborators
-
VA Pittsburgh Healthcare System
collaborator FED -
American Society for Gastrointestinal Endoscopy
collaborator OTHER -
University of Pittsburgh
lead OTHER
Principal Investigators
-
Asif Khalid, MD · University of Pittsburgh
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-06-30
Countries
- United States
Study Locations
More Related Trials
-
Genomic Profiling of Pancreatic Cystic Tumors
NCT06195904 ·Status: NOT_YET_RECRUITING
-
Application of Chromosomal Instability in Early Diagnosis of Biliary Tract Carcinoma
NCT05845554 ·Status: RECRUITING
-
Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC
NCT03302325 ·Status: COMPLETED
-
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
NCT06958107 ·Status: RECRUITING
-
RNA Sequencing of Solid and Cystic Lesions of the Pancreas
NCT01807325 ·Status: COMPLETED
-
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer
NCT03214991 ·Status: UNKNOWN
-
Cohort Study of Pancreatic Cancer Risk
NCT04247503 ·Status: ACTIVE_NOT_RECRUITING
-
DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer
NCT02079363 ·Status: UNKNOWN
-
Urine Methylation Markers in UTUC
NCT06805630 ·Status: RECRUITING ·Phase: NA
-
Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer
NCT04253106 ·Status: COMPLETED ·Phase: NA
-
Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
NCT05379907 ·Status: WITHDRAWN
-
Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability
NCT05853198 ·Status: RECRUITING ·Phase: NA
-
Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
NCT05737953 ·Status: RECRUITING
-
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
NCT04213326 ·Status: COMPLETED
-
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
NCT00213798 ·Status: COMPLETED ·Phase: NA
-
Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies
NCT04566614 ·Status: COMPLETED
-
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
NCT02790944 ·Status: COMPLETED
-
Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
NCT01187602 ·Status: UNKNOWN
-
SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer
NCT00900042 ·Status: COMPLETED
-
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
NCT02441140 ·Status: TERMINATED ·Phase: NA
-
Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description
NCT05029869 ·Status: ACTIVE_NOT_RECRUITING
-
Pancreatic Cancer Screening of High-Risk Individuals in Arkansas
NCT02309632 ·Status: WITHDRAWN ·Phase: NA
-
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
NCT05497531 ·Status: RECRUITING ·Phase: NA
-
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
NCT00489515 ·Status: COMPLETED
-
A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
NCT00001938 ·Status: COMPLETED